Clinical trial ANITA
A phase II multicenter study comparing the efficacy of the oral angiogenesis inhibitor nintedanib with the intravenous cytotoxic compound ifosfamide for treatment of patients with advanced metastatic soft tissue sarcoma after failure of systemic non-oxazaphosphorine-based first line chemotherapy for inoperable disease
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | EORTC |
| EudraCT Identifier | 2016-002093-12 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02808247 |
| Inclusion criteria | second line metastatic |
| Last update |